@article{23550,
  author = {Cooper M and Toto R and Zinman B and Perkovic V and Rosenstock J and Alexander J and Marx N and Pencina M and Wanner C and Baanstra D and Pfarr E and Mattheus M and Broedl U and Woerle H and George J and von E and McGuire D},
  title = {Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): A randomized, double-blind, placebo-control},
  year = {2018},
  journal = {Cardiovascular Diabetology},
  volume = {17},
  doi = {10.1186/s12933-018-0682-3},
  language = {eng},
}